Compare Illumina, Inc. (ILMN) vs TotalEnergies SE (TTE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Illumina, Inc. vs TotalEnergies SE — how do they compare? Illumina, Inc. trades at $264.24 (market cap $40.43B), while TotalEnergies SE trades at $86.07 (market cap $187.35B). The key difference: TotalEnergies SE is far larger — about 4.6× Illumina, Inc.'s market cap, and TotalEnergies SE pays a 5.03% dividend while Illumina, Inc. pays none. Which is the better fit depends on your goals — on Pluang, investors hold Illumina, Inc. for 83 Days and TotalEnergies SE for 90 Days on average.
| ILMN | TTE | |
|---|---|---|
Market Cap | $40.43B | $187.35B |
Volume | 2,948,626 | 1,924,317 |
Sector | Health | Energy |
52-Week High | $293.69 | $93.60 |
52-Week Low | $91.00 | $57.39 |
Typical Hold Time | 83 Days | 90 Days |
Enterprise Value | $41.79B | $218.34B |
Dividend Yield | — | 5.03% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Illumina (ILMN) trades at $264.40, down 3.34% on the day but up significantly year-to-date with strong technical momentum. The stock shows bullish moving average signals and trades near pivot point resistance at $268. Fundamentally, the company has delivered three consecutive quarterly earnings beats and returned to profitability in 2025 with $850 million net income after previous losses. Recent catalysts include S&P 500 inclusion effective September 21, 2026, and growing AI integration in genomics applications.
The outlook remains positive with analyst consensus favoring Buy ratings (54%) and a $241 price target, though current price exceeds consensus. Key opportunities include sequencing growth and AI-driven biological data expansion, while risks involve China market headwinds and elevated valuation multiples. Earnings growth and S&P 500 inclusion provide near-term catalysts, but the stock trades at premium valuations with P/E of 49.96 requiring sustained execution.
TotalEnergies (TTE) trades at $86.02, up 2.43% with strong earnings beats in Q1 and Q2 2026. The stock shows attractive valuation metrics with P/E of 10.54 and P/S of 0.94, while maintaining solid profitability with 9.08% net margin. Recent news highlights $10 billion Argentina investment and strategic growth plans through 2030, though technical indicators signal bearish momentum with key support at $83-84 levels.
TTE presents value opportunity with discounted valuation and dividend growth strategy, but faces headwinds from declining revenue trends and bearish technical setup. The 17% upside to consensus price target of $95.33 and 55.88% analyst buy rating support bullish case, though investors should monitor oil price volatility and execution of new investments.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Illumina, Inc.
Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (less than 10% of sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.
Read more on ILMN →About TotalEnergies SE
TotalEnergies is an integrated oil and gas company that explores for, produces, and refines oil around the world. In 2021, it produced 1.5 million barrels of liquids and 7.2 billion cubic feet of natural gas per day. At year-end 2020, reserves stood at 12.1 billion barrels of oil equivalent, 45% of which are liquids. During 2021, it had LNG sales of 42 Mt. The company owns interests in refineries with capacity of nearly 1.8 million barrels a day, primarily in Europe, distributes refined products in 65 countries, and manufactures commodity and specialty chemicals. It also holds a 19% interest in Russian oil company Novatek. At year-end, its gross installed renewable power generation capacity was 10.3 GW.
Read more on TTE →
